← All companies

DGX

Quest Diagnostics Incorporated

DGX NYSE Services-Medical Laboratories EDGAR ↗

$231.95

-1.06 -0.45%

Key statistics

from XBRL data in SEC filings

Market cap

$25.6B

Revenue (TTM)

$11.6B

Net income (TTM)

$1.06B

EPS (TTM)

$9.42

P/E ratio

24.6

Dividend yield

1.43%

Free cash flow

$1.36B

Cash

$626M

Total assets

$16.9B

Gross margin

31.4%

52-week range

$171.18 – $240.13

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 23, 2026 8-K Results of operations (earnings release) Jul 23, 2026 8-K Shareholder vote results May 21, 2026 8-K Entered a material agreement May 8, 2026 8-K Other events May 1, 2026 10-Q Quarter ended 2026-03-31 Apr 22, 2026 8-K Results of operations (earnings release) Apr 21, 2026 8-K Director or officer change; Regulation FD disclosure Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Other events Feb 10, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release) Oct 21, 2025 10-Q Quarter ended 2025-09-30 Oct 21, 2025 10-Q Quarter ended 2025-06-30 Jul 23, 2025 8-K Results of operations (earnings release) Jul 22, 2025 8-K Shareholder vote results May 22, 2025 10-Q Quarter ended 2025-03-31 Apr 23, 2025 8-K Results of operations (earnings release) Apr 22, 2025 8-K Regulation FD disclosure Mar 19, 2025 8-K Regulation FD disclosure Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release); Other events Jan 30, 2025 10-Q Quarter ended 2024-09-30 Oct 23, 2024 8-K Results of operations (earnings release) Oct 22, 2024 8-K Other events Aug 29, 2024 8-K Entered a material agreement; Amended charter or bylaws; Other events Aug 19, 2024 10-Q Quarter ended 2024-06-30 Jul 24, 2024 8-K Results of operations (earnings release) Jul 23, 2024 8-K Entered a material agreement; Regulation FD disclosure Jul 3, 2024 8-K Director or officer change; Regulation FD disclosure May 21, 2024 8-K Amended charter or bylaws; Shareholder vote results May 21, 2024 10-Q Quarter ended 2024-03-31 Apr 24, 2024 8-K Results of operations (earnings release) Apr 23, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release); Other events Feb 1, 2024 8-K Entered a material agreement; Other events Nov 1, 2023 10-Q Quarter ended 2023-09-30 Oct 25, 2023 8-K Results of operations (earnings release) Oct 24, 2023 8-K Director or officer change Sep 29, 2023 10-Q Quarter ended 2023-06-30 Jul 27, 2023